Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
about
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure.Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)Is antibiotic resistance a problem? A practical guide for hospital clinicians.Measurement of ceftazidime concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry. Application to critically ill patients and patients with osteoarticular infections.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Ceftazidime for respiratory infections.Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters.Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?Physical and chemical compatibility of daptomycin with nine medications.Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.Warming of infusion syringes caused by electronic syringe pumps.
P2860
Q33938048-EDA3E335-4332-44B2-A995-62365EF715EAQ34111057-A8E7F4F9-6FA1-4563-B1BA-CB29970FCBF6Q35523222-BD58DE29-9630-44C8-8DB4-316DC77D76BFQ35694058-7923F1C3-6A4A-488A-82F5-5870FDBF115FQ38004063-1DB86C11-BC6B-455E-835F-2B0D34CA5046Q38040144-64AFF26C-8733-4CF9-8EB6-BF70A3030301Q39085560-B565E566-DDA4-424C-9F9D-8097D1888A99Q41644266-025C4958-1070-4BDC-A3AC-5EFEFF05F862Q42432137-964EBC35-DDFD-4E8C-8296-70B540E02971Q45029806-B2F391DC-1432-4E2E-944E-52A73DF73996Q46857071-F6D26BA0-05AF-407B-ABB2-2D67CF7B90D2Q51299981-A173ACD5-B5AE-4EB1-A4DB-D6EC131DAA49
P2860
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Stability and compatibility of ...... on to intensive care patients.
@ast
Stability and compatibility of ...... on to intensive care patients.
@en
type
label
Stability and compatibility of ...... on to intensive care patients.
@ast
Stability and compatibility of ...... on to intensive care patients.
@en
prefLabel
Stability and compatibility of ...... on to intensive care patients.
@ast
Stability and compatibility of ...... on to intensive care patients.
@en
P2860
P1476
Stability and compatibility of ...... on to intensive care patients.
@en
P2093
P M Tulkens
P2860
P304
P356
10.1128/AAC.45.9.2643-2647.2001
P407
P577
2001-09-01T00:00:00Z